LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 70.81 | 84.90 | 4052 | 9132 | 0.4437 | 0.7731 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 72.52 | 84.90 | 66 | 9214 | 0.0072 | -0.0366 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 72.52 | 84.90 | 4277 | 9214 | 0.4642 | 0.7854 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 72.52 | 84.90 | 135 | 9214 | 0.0147 | 0.0710 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 72.52 | 84.90 | 3136 | 9214 | 0.3403 | 0.7053 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 72.52 | 84.90 | 4162 | 9214 | 0.4517 | 0.7782 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 72.52 | 84.90 | 4235 | 9214 | 0.4596 | 0.7828 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 74.22 | 84.90 | 33 | 9343 | 0.0035 | -0.1301 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 74.22 | 84.90 | 4378 | 9343 | 0.4686 | 0.7885 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 74.22 | 84.90 | 128 | 9343 | 0.0137 | 0.0624 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 74.22 | 84.90 | 3246 | 9343 | 0.3474 | 0.7113 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 74.22 | 84.90 | 4249 | 9343 | 0.4548 | 0.7806 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 74.22 | 84.90 | 4370 | 9343 | 0.4677 | 0.7880 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 75.93 | 84.90 | 48 | 8970 | 0.0054 | -0.0813 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 75.93 | 84.90 | 4539 | 8970 | 0.5060 | 0.8073 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 75.93 | 84.90 | 133 | 8970 | 0.0148 | 0.0690 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 75.93 | 84.90 | 3341 | 8970 | 0.3724 | 0.7268 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 75.93 | 84.90 | 4444 | 8970 | 0.4954 | 0.8016 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 75.93 | 84.90 | 4563 | 8970 | 0.5087 | 0.8087 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 77.64 | 84.90 | 75 | 9245 | 0.0081 | -0.0182 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 77.64 | 84.90 | 4670 | 9245 | 0.5051 | 0.8080 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 77.64 | 84.90 | 144 | 9245 | 0.0156 | 0.0812 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 77.64 | 84.90 | 3506 | 9245 | 0.3792 | 0.7330 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 77.64 | 84.90 | 4600 | 9245 | 0.4975 | 0.8040 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 77.64 | 84.90 | 4724 | 9245 | 0.5109 | 0.8111 | MN20160318_Q02 | K06 |